Proteinases in cutaneous wound healing

Cellular and Molecular Life Sciences

Volumn 66, Issue 2, 2009, Pages 203-224

  Toriseva, M ^a,b   Kahari V M ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

ADAM; ADAMTS; Fibrosis; MMP; Plasminogen; Skin; Wound

Indexed keywords

ADAM PROTEIN; DOXYCYCLINE; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; PLASMIN; PLASMINOGEN; PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR;

CHRONIC WOUND; CLINICAL TRIAL; DIABETIC FOOT; ENZYME ACTIVITY; GRANULATION TISSUE; HEMOSTASIS; HUMAN; INFLAMMATION; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; SCAR; SCAR FORMATION; SKIN INJURY; SKIN ULCER; WOUND CONTRACTION; WOUND HEALING;

ADAM PROTEINS; ANIMALS; CICATRIX; HUMANS; MATRIX METALLOPROTEINASES; MODELS, BIOLOGICAL; PEPTIDE HYDROLASES; PLASMIN; SKIN; TISSUE INHIBITOR OF METALLOPROTEINASES; WOUND HEALING;

EID: 59149104284     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8388-4     Document Type: Review

References (232)

1. Clark, R. A. F. (1995) Wound repair: Overview and general considerations. In: The molecular and cellular biology of wound repair (2nd edition), pp. 513-560, Plenum Press, New York.
2. Singer, A. J. and Clark, R. A. (1999) Cutaneous wound healing. N. Engl. J. Med. 341, 738-746.
3. Egozi, E. I., Ferreira, A. M., Burns, A. L., Gamelli, R. L. and Dipietro, L. A. (2003) Mast cells modulate the inflammatory but not the proliferative response in healing wounds. Wound Repair Regen. 11, 46-54.
4. Eming, S. A., Krieg, T. and Davidson, J. M. (2007) Inflammation in wound repair: molecular and cellular mechanisms. J. Invest. Dermatol. 127, 514-525.
5. Levy, V., Lindon, C., Zheng, Y., Harfe, B. D. and Morgan, B. A. (2007) Epidermal stem cells arise from the hair follicle after wounding. FASEB J. 21, 1358-1366.
6. Opalenik, S. R. and Davidson, J. M. (2005) Fibroblast differentiation of bone marrow-derived cells during wound repair. FASEB J. 19, 1561-1563.
7. Welch, M. P., Odland, G. F. and Clark, R. A. (1990) Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J. Cell Biol. 110, 133-145.
8. Hinz, B., Mastrangelo, D., Iselin, C. E., Chaponnier, C. and Gabbiani, G. (2001) Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am. J. Pathol. 159, 1009-1020.
9. Hinz, B. (2007) Formation and function of the myofibroblast during tissue repair. J. Invest. Dermatol. 127, 526-537.
10. Chmielowiec, J., Borowiak, M., Morkel, M., Stradal, T., Munz, B., Werner, S., Wehland, J., Birchmeier, C. and Birchmeier, W. (2007) c-Met is essential for wound healing in the skin. J. Cell Biol. 177, 151-162.
11. Werner, S. and Grose, R. (2003) Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83, 835-870.
12. Werner, S., Krieg, T. and Smola, H. (2007) Keratinocyte-fibroblast interactions in wound healing. J. Invest. Dermatol. 127, 998-1008.
13. Schäfer, M. and Werner, S. (2007) Transcriptional Control of Wound Repair. Annu. Rev. Cell Dev. Biol. 13, 69-92.
14. Cesarman-Maus, G. and Hajjar, K. A. (2005) Molecular mechanisms of fibrinolysis. Br. J. Haematol. 129, 307-321.
15. Rawlings, N. D., Morton, F. R. and Barrett, A. J. (2006) MEROPS: the peptidase database. Nucleic Acids Res. 34, D270-272.
16. Lund, L. R., Green, K. A., Stoop, A. A., Ploug, M., Almholt, K., Lilla, J., Nielsen, B. S., Christensen, I. J., Craik, C. S., Werb, Z., Dano, K. and Rømer, J. (2006) Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J. 25, 2686-2697.
17. Colman, R. W. (1969) Activation of plasminogen by human plasma kallikrein. Biochem. Biophys. Res. Commun. 35, 273-279.
18. Goldsmith, G. H., Jr., Saito, H. and Ratnoff, O. S. (1978) The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments. J. Clin. Invest. 62, 54-60.
19. Goldfinger, L. E., Stack, M. S. and Jones, J. C. (1998) Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator. J. Cell Biol. 141, 255-265.
20. Bonnefoy, A. and Legrand, C. (2000) Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase. Thromb. Res. 98, 323-332.
21. Lyons, R. M., Gentry, L. E., Purchio, A. F. and Moses, H. L. (1990) Mechanism of activation of latent recombinant transforming growth factor-b1 by plasmin. J. Cell Biol. 110, 1361-1367.
22. Vihinen, P. and Kähäri, V.-M. (2002) Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int. J. Cancer 99, 157-166.
23. Menshikov, M., Elizarova, E., Plakida, K., Timofeeva, A., Khaspekov, G., Beabealashvilli, R., Bobik, A. and Tkachuk, V. (2002) Urokinase upregulates matrix metalloproteinase-9 expression in THP-1 monocytes via gene transcription and protein synthesis. Biochem. J. 367, 833-839.
24. Zhang, Y., Zhou, Z. H., Bugge, T. H. and Wahl, L. M. (2007) Urokinase-type plasminogen activator stimulation of monocyte matrix metalloproteinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin. J. Immunol. 179, 3297-3304.
25. Hu, K., Yang, J., Tanaka, S., Gonias, S. L., Mars, W. M. and Liu, Y. (2006) Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression. J. Biol. Chem. 281, 2120-2127.
26. Tabruyn, S. P. and Griffioen, A. W. (2007) Molecular pathways of angiogenesis inhibition. Biochem. Biophys. Res. Commun. 355, 1-5.
27. Sternlicht, M. D. and Werb, Z. (2001) How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463-516.
28. Parks, W. C., Wilson, C. L. and Lopez-Boado, Y. S. (2004) Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4, 617-629.
29. Cauwe, B., Van den Steen, P. E. and Opdenakker, G. (2007) The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit. Rev. Biochem. Mol. Biol. 42, 113-185.
30. Nagase, H., Visse, R. and Murphy, G. (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 69, 562-573.
31. Limb, G. A., Matter, K., Murphy, G., Cambrey, A. D., Bishop, P. N., Morris, G. E. and Khaw, P. T. (2005) Matrix metalloproteinase-1 associates with intracellular organelles and confers resistance to lamin A/C degradation during apoptosis. Am. J. Pathol. 166, 1555-1563.
32. Luo, D., Mari, B., Stoll, I. and Anglard, P. (2002) Alternative splicing and promoter usage generates an intracellular stromelysin 3 isoform directly translated as an active matrix metalloproteinase. J. Biol. Chem. 277, 25527-25536.
33. Kwan, J. A., Schulze, C. J., Wang, W., Leon, H., Sariahmetoglu, M., Sung, M., Sawicka, J., Sims, D. E., Sawicki, G. and Schulz, R. (2004) Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro. FASEB J. 18, 690-692.
34. McCawley, L. J. and Matrisian, L. M. (2001) Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell Biol. 13, 534-540.
35. Burrage, P. S., Mix, K. S. and Brinckerhoff, C. E. (2006) Matrix metalloproteinases: role in arthritis. Front. Biosci. 11, 529-543.
36. Newby, A. C. (2005) Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol. Rev. 85, 1-31.
37. Gueders, M. M., Foidart, J. M., Noel, A. and Cataldo, D. D. (2006) Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur. J. Pharmacol. 533, 133-144.
38. Folgueras, A. R., Pendas, A. M., Sanchez, L. M. and Lopez-Otin, C. (2004) Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int. J. Dev. Biol. 48, 411-424.
39. Ala-aho, R. and Kähäri, V.-M. (2005) Collagenases in cancer. Biochimie 87, 273-286.
40. Sorsa, T., Tjäderhane, L., Konttinen, Y. T., Lauhio, A., Salo, T., Lee, H. M., Golub, L. M., Brown, D. L. and Mäntylä, P. (2006) Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann. Med. 38, 306-321.
41. Ravanti, L. and Kähäri, V.-M. (2000) Matrix metalloproteinases in wound repair (review). Int. J. Mol. Med. 6, 391-407.
42. Vaalamo, M., Karjalainen-Lindsberg, M.-L., Puolakkainen, P., Kere, J. and Saarialho-Kere, U. (1998) Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophagemetalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am. J. Pathol. 152, 1005-1014.
43. Page-McCaw, A., Ewald, A. J. and Werb, Z. (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8, 221-233.
44. Baker, A. H., Edwards, D. R. and Murphy, G. (2002) Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 115, 3719-3727.
45. Rhee, J. S. and Coussens, L. M. (2002) RECKing MMP function: implications for cancer development. Trends Cell Biol. 12, 209-211.
46. Emonard, H., Bellon, G., de Diesbach, P., Mettlen, M., Hornebeck, W. and Courtoy, P. J. (2005) Regulation of matrix metalloproteinase (MMP) activity by the low-density lipoprotein receptor-related protein (LRP). A new function for an "old friend". Biochimie 87, 369-376.
47. Osenkowski, P., Toth, M. and Fridman, R. (2004) Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP). J. Cell. Physiol. 200, 2-10.
48. Yan, C. and Boyd, D. D. (2007) Regulation of matrix metalloproteinase gene expression. J. Cell. Physiol. 211, 19-26.
49. Westermarck, J., Holmström, T. H., Ahonen, M., Eriksson, J. E. and Kähäri, V.-M. (1998) Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38. Matrix Biol. 17, 547-557.
50. Pilcher, B. K., Gaither-Ganim, J., Parks, W. C. and Welgus, H. G. (1997) Cell type-specific inhibition of keratinocyte collagenase-1 expression by basic fibroblast growth factor and keratinocyte growth factor. A common receptor pathway. J. Biol. Chem. 272, 18147-18154.
51. Bauer, E. A., Cooper, T. W., Huang, J. S., Altman, J. and Deuel, T. F. (1985) Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor. Proc. Natl. Acad. Sci. U. S. A. 82, 4132-4136.
52. Yuan, W. and Varga, J. (2001) Transforming growth factor-β repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3. J. Biol. Chem. 276, 38502-38510.
53. Seals, D. F. and Courtneidge, S. A. (2003) The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 17, 7-30.
54. Huovila, A. P., Turner, A. J., Pelto-Huikko, M., Kärkkäinen, I. and Ortiz, R. M. (2005) Shedding light on ADAM metalloproteinases. Trends Biochem. Sci. 30, 413-422.
55. Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., Boyce, R. W., Nelson, N., Kozlosky, C. J., Wolfson, M. F., Rauch, C. T., Cerretti, D. P., Paxton, R. J., March, C. J. and Black, R. A. (1998) An essential role for ectodomain shedding in mammalian development. Science 282, 1281-1284.
56. Shi, W., Chen, H., Sun, J., Buckley, S., Zhao, J., Anderson, K. D., Williams, R. G. and Warburton, D. (2003) TACE is required for fetal murine cardiac development and modeling. Dev. Biol. 261, 371-380.
57. Hartmann, D., de Strooper, B., Serneels, L., Craessaerts, K., Herreman, A., Annaert, W., Umans, L., Lubke, T., Lena Illert, A., von Figura, K. and Saftig, P. (2002) The disintegrin/ metalloprotease ADAM 10 is essential for Notch signalling but not for a-secretase activity in fibroblasts. Hum. Mol. Genet. 11, 2615-2624.
58. Zhou, H. M., Weskamp, G., Chesneau, V., Sahin, U., Vortkamp, A., Horiuchi, K., Chiusaroli, R., Hahn, R., Wilkes, D., Fisher, P., Baron, R., Manova, K., Basson, C. T., Hempstead, B. and Blobel, C. P. (2004) Essential role for ADAM19 in cardiovascular morphogenesis. Mol. Cell. Biol. 24, 96-104.
59. Sahin, U., Weskamp, G., Kelly, K., Zhou, H. M., Higashiyama, S., Peschon, J., Hartmann, D., Saftig, P. and Blobel, C. P. (2004) Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 164, 769-779.
60. Sahin, U. and Blobel, C. P. (2007) Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17. FEBS Lett. 581, 41-44.
61. Schwettmann, L. and Tschesche, H. (2001) Cloning and expression in Pichia pastoris of metalloprotease domain of ADAM 9 catalytically active against fibronectin. Protein Expr. Purif. 21, 65-70.
62. Millichip, M. I., Dallas, D. J., Wu, E., Dale, S. and McKie, N. (1998) The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Biochem. Biophys. Res. Commun. 245, 594-598.
63. Martin, J., Eynstone, L. V., Davies, M., Williams, J. D. and Steadman, R. (2002) The role of ADAM 15 in glomerular mesangial cell migration. J. Biol. Chem. 277, 33683-33689.
64. Bridges, L. C. and Bowditch, R. D. (2005) ADAM-Integrin Interactions: potential integrin regulated ectodomain shedding activity. Curr. Pharm. Des. 11, 837-847.
65. Mochizuki, S., Shimoda, M., Shiomi, T., Fujii, Y. and Okada, Y. (2004) ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3. Biochem. Biophys. Res. Commun. 315, 79-84.
66. Zou, J., Zhu, F., Liu, J., Wang, W., Zhang, R., Garlisi, C. G., Liu, Y. H., Wang, S., Shah, H., Wan, Y. and Umland, S. P. (2004) Catalytic activity of human ADAM33. J. Biol. Chem. 279, 9818-9830.
67. Apte, S. S. (2004) A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family. Int. J. Biochem. Cell Biol. 36, 981-985.
68. Porter, S., Clark, I. M., Kevorkian, L. and Edwards, D. R. (2005) The ADAMTS metalloproteinases. Biochem. J. 386, 15-27.
69. Colige, A., Ruggiero, F., Vandenberghe, I., Dubail, J., Kesteloot, F., Van Beeumen, J., Beschin, A., Brys, L., Lapiere, C. M. and Nusgens, B. (2005) Domains and maturation processes that regulate the activity of ADAMTS-2, a metalloproteinase cleaving the aminopropeptide of fibrillar procollagens types I-III and V. J. Biol. Chem. 280, 34397-34408.
70. Fernandes, R. J., Hirohata, S., Engle, J. M., Colige, A., Cohn, D. H., Eyre, D. R. and Apte, S. S. (2001) Procollagen II amino propeptide processing by ADAMTS-3. Insights on dermatosparaxis. J. Biol. Chem. 276, 31502-31509.
71. Vazquez, F., Hastings, G., Ortega, M. A., Lane, T. F., Oikemus, S., Lombardo, M. and Iruela-Arispe, M. L. (1999) METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J. Biol. Chem. 274, 23349-23357.
72. Luque, A., Carpizo, D. R. and Iruela-Arispe, M. L. (2003) ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165. J. Biol. Chem. 278, 23656-23665.
73. Rodriguez-Manzaneque, J. C., Westling, J., Thai, S. N., Luque, A., Knäuper, V., Murphy, G., Sandy, J. D. and Iruela-Arispe, M. L. (2002) ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors. Biochem. Biophys. Res. Commun. 293, 501-508.
74. Rømer, J., Lund, L. R., Eriksen, J., Ralfkiaer, E., Zeheb, R., Gelehrter, T. D., Dano, K. and Kristensen, P. (1991) Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds. J. Invest. Dermatol. 97, 803-811.
75. Rømer, J., Lund, L. R., Eriksen, J., Pyke, C., Kristensen, P. and Dano, K. (1994) The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds. J. Invest. Dermatol. 102, 519-522.
76. Rømer, J., Bugge, T. H., Pyke, C., Lund, L. R., Flick, M. J., Degen, J. L. and Dano, K. (1996) Impaired wound healing in mice with a disrupted plasminogen gene. Nat. Med. 2, 287-292.
77. Vaalamo, M., Weckroth, M., Puolakkainen, P., Kere, J., Saarinen, P., Lauharanta, J. and Saarialho-Kere, U. K. (1996) Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br. J. Dermatol. 135, 52-59.
78. Ando, Y. and Jensen, P. J. (1996) Protein kinase C mediates up-regulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro. J. Cell. Physiol. 167, 500-511.
79. Sato, C., Tsuboi, R., Shi, C. M., Rubin, J. S. and Ogawa, H. (1995) Comparative study of hepatocyte growth factor/scatter factor and keratinocyte growth factor effects on human keratinocytes. J. Invest. Dermatol. 104, 958-963.
80. Keski-Oja, J. and Koli, K. (1992) Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-β1. J. Invest. Dermatol. 99, 193-200.
81. Lian, X., Yang, L., Gao, Q. and Yang, T. (2008) IL-1α is a potent stimulator of keratinocyte tissue plasminogen activator expression and regulated by TGF-β1. Arch. Dermatol. Res. 300, 185-193.
82. Schäfer, B. M., Maier, K., Eickhoff, U., Todd, R. F. and Kramer, M. D. (1994) Plasminogen activation in healing human wounds. Am. J. Pathol. 144, 1269-1280.
83. Bugge, T. H., Kombrinck, K. W., Flick, M. J., Daugherty, C. C., Danton, M. J. and Degen, J. L. (1996) Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 87, 709-719.
84. Lund, L. R., Rømer, J., Bugge, T. H., Nielsen, B. S., Frandsen, T. L., Degen, J. L., Stephens, R. W. and Dano, K. (1999) Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J. 18, 4645-4656.
85. Pepper, M. S. (2001) Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 21, 1104-1117.
86. Whitelock, J. M., Murdoch, A. D., Iozzo, R. V. and Underwood, P. A. (1996) The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J. Biol. Chem. 271, 10079-10086.
87. Park, J. E., Keller, G. A. and Ferrara, N. (1993) The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell 4, 1317-1326.
88. Saarialho-Kere, U. K., Crouch, E. C. and Parks, W. C. (1995) Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J. Invest. Dermatol. 105, 190-196.
89. Sadowski, T., Dietrich, S., Muller, M., Havlickova, B., Schunck, M., Proksch, E., Muller, M. S. and Sedlacek, R. (2003) Matrix metalloproteinase-19 expression in normal and diseased skin: dysregulation by epidermal proliferation. J. Invest. Dermatol. 121, 989-996.
90. Lohi, J., Wilson, C. L., Roby, J. D. and Parks, W. C. (2001) Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J. Biol. Chem. 276, 10134-10144.
91. Madlener, M., Parks, W. C. and Werner, S. (1998) Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp. Cell Res. 242, 201-210.
92. Ågren, M. S. (1994) Gelatinase activity during wound healing. Br. J. Dermatol. 131, 634-640.
93. Inoue, M., Kratz, G., Haegerstrand, A. and Stahle-Backdahl, M. (1995) Collagenase expression is rapidly induced in wound-edge keratinocytes after acute injury in human skin, persists during healing, and stops at re-epithelialization. J. Invest. Dermatol. 104, 479-483.
94. Nwomeh, B. C., Liang, H. X., Cohen, I. K. and Yager, D. R. (1999) MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J. Surg. Res. 81, 189-195.
95. Mirastschijski, U., Impola, U., Jahkola, T., Karlsmark, T., Ågren, M. S. and Saarialho-Kere, U. (2002) Ectopic localization of matrix metalloproteinase-9 in chronic cutaneous wounds. Hum. Pathol. 33, 355-364.
96. Hieta, N., Impola, U., Lopez-Otin, C., Saarialho-Kere, U. and Kähäri, V.-M. (2003) Matrix metalloproteinase-19 expression in dermal wounds and by fibroblasts in culture. J. Invest. Dermatol. 121, 997-1004.
97. Ahokas, K., Skoog, T., Suomela, S., Jeskanen, L., Impola, U., Isaka, K. and Saarialho-Kere, U. (2005) Matrilysin-2 (matrix metalloproteinase-26) is upregulated in keratinocytes during wound repair and early skin carcinogenesis. J. Invest. Dermatol. 124, 849-856.
98. Vaalamo, M., Leivo, T. and Saarialho-Kere, U. (1999) Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum. Pathol. 30, 795-802.
99. Saarialho-Kere, U. K., Kovacs, S. O., Pentland, A. P., Olerud, J. E., Welgus, H. G. and Parks, W. C. (1993) Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J. Clin. Invest. 92, 2858-2866.
100. Sudbeck, B. D., Pilcher, B. K., Welgus, H. G. and Parks, W. C. (1997) Induction and repression of collagenase-1 by keratinocytes is controlled by distinct components of different extracellular matrix compartments. J. Biol. Chem. 272, 22103-22110.
101. Pilcher, B. K., Dumin, J. A., Sudbeck, B. D., Krane, S. M., Welgus, H. G. and Parks, W. C. (1997) The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J. Cell Biol. 137, 1445-1457.
102. Dumin, J. A., Dickeson, S. K., Stricker, T. P., Bhattacharyya-Pakrasi, M., Roby, J. D., Santoro, S. A. and Parks, W. C. (2001) Pro-collagenase-1 (matrix metalloproteinase-1) binds the α2β1 integrin upon release from keratinocytes migrating on type I collagen. J. Biol. Chem. 276, 29368-29374.
103. Grenache, D. G., Zhang, Z., Wells, L. E., Santoro, S. A., Davidson, J. M. and Zutter, M. M. (2007) Wound healing in the α2β1 integrin-deficient mouse: altered keratinocyte biology and dysregulated matrix metalloproteinase expression. J. Invest. Dermatol. 127, 455-466.
104. Di Colandrea, T., Wang, L., Wille, J., D'Armiento, J. and Chada, K. K. (1998) Epidermal expression of collagenase delays wound-healing in transgenic mice. J. Invest. Dermatol. 111, 1029-1033.
105. Beare, A. H., O'Kane, S., Krane, S. M. and Ferguson, M. W. (2003) Severely impaired wound healing in the collagenase-resistant mouse. J. Invest. Dermatol. 120, 153-163.
106. Vaalamo, M., Mattila, L., Johansson, N., Kariniemi, A.-L., Karjalainen-Lindsberg, M.-L., Kähäri, V.-M. and Saarialho-Kere, U. (1997) Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1(MMP-1) in chronic ulcers but not in normally healing wounds. J. Invest. Dermatol. 109, 96-101.
107. Pins, G. D., Collins-Pavao, M. E., Van De Water, L., Yarmush, M. L. and Morgan, J. R. (2000) Plasmin triggers rapid contraction and degradation of fibroblast-populated collagen lattices. J. Invest. Dermatol. 114, 647-653.
108. Ravanti, L., Toriseva, M., Penttinen, R., Crombleholme, T., Foschi, M., Han, J. and Kähäri, V.-M. (2001) Expression of human collagenase-3 (MMP-13) by fetal skin fibroblasts is induced by transforming growth factor b via p38 mitogen-activated protein kinase. FASEB J. 15, 1098-1100.
109. Grinnell, F. (2003) Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol. 13, 264-269.
110. Toriseva, M. J., Ala-aho, R., Karvinen, J., Baker, A. H., Marjomaki, V. S., Heino, J. and Kähäri, V.-M. (2007) Collagenase-3 (MMP-13) enhances remodeling of three-dimensional collagen and promotes survival of human skin fibroblasts. J. Invest. Dermatol. 127, 49-59.
111. Bao, W. and Strömblad, S. (2004) Integrin αv-mediated inactivation of p53 controls a MEK1-dependent melanoma cell survival pathway in three-dimensional collagen. J. Cell Biol. 167, 745-756.
112. Hartenstein, B., Dittrich, B. T., Stickens, D., Heyer, B., Vu, T. H., Teurich, S., Schorpp-Kistner, M., Werb, Z. and Angel, P. (2006) Epidermal development and wound healing in matrix metalloproteinase 13-deficient mice. J. Invest. Dermatol. 126, 486-496.
113. Parks, W. C. (2007) What is the α2β1 integrin doing in the epidermis? J. Invest. Dermatol. 127, 264-266.
114. Hasty, K. A., Hibbs, M. S., Kang, A. H. and Mainardi, C. L. (1986) Secreted forms of human neutrophil collagenase. J. Biol. Chem. 261, 5645-5650.
115. Gutierrez-Fernandez, A., Inada, M., Balbin, M., Fueyo, A., Pitiot, A. S., Astudillo, A., Hirose, K., Hirata, M., Shapiro, S. D., Noel, A., Werb, Z., Krane, S. M., Lopez-Otin, C. and Puente, X. S. (2007) Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J. 21, 2580-2591.
116. Rechardt, O., Elomaa, O., Vaalamo, M., Paakkonen, K., Jahkola, T., Höök-Nikanne, J., Hembry, R. M., Häkkinen, L., Kere, J. and Saarialho-Kere, U. (2000) Stromelysin-2 is upregulated during normal wound repair and is induced by cytokines. J. Invest. Dermatol. 115, 778-787.
117. Bullard, K. M., Lund, L., Mudgett, J. S., Mellin, T. N., Hunt, T. K., Murphy, B., Ronan, J., Werb, Z. and Banda, M. J. (1999) Impaired wound contraction in stromelysin-1-deficient mice. Ann. Surg. 230, 260-265.
118. Visse, R. and Nagase, H. (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92, 827-839.
119. Noe, V., Fingleton, B., Jacobs, K., Crawford, H. C., Vermeulen, S., Steelant, W., Bruyneel, E., Matrisian, L. M. and Mareel, M. (2001) Release of an invasion promoter Ecadherin fragment by matrilysin and stromelysin-1. J. Cell Sci. 114, 111-118.
120. Krampert, M., Bloch, W., Sasaki, T., Bugnon, P., Rulicke, T., Wolf, E., Aumailley, M., Parks, W. C. and Werner, S. (2004) Activities of the matrix metalloproteinase stromelysin-2 (MMP-10) in matrix degradation and keratinocyte organization in wounded skin. Mol. Biol. Cell 15, 5242-5254.
121. Leppert, D., Waubant, E., Galardy, R., Bunnett, N. W. and Hauser, S. L. (1995) T cell gelatinases mediate basement membrane transmigration in vitro. J. Immunol. 154, 4379-4389.
122. Okada, S., Kita, H., George, T. J., Gleich, G. J. and Leiferman, K. M. (1997) Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am. J. Respir. Cell Mol. Biol. 17, 519-528.
123. Yu, Q. and Stamenkovic, I. (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev. 14, 163-176.
124. Dallas, S. L., Rosser, J. L., Mundy, G. R. and Bonewald, L. F. (2002) Proteolysis of latent transforming growth factor-β (TGF-β)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-β from bone matrix. J. Biol. Chem. 277, 21352-21360.
125. Imai, K., Hiramatsu, A., Fukushima, D., Pierschbacher, M. D. and Okada, Y. (1997) Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-β1 release. Biochem. J. 322 ( Pt 3), 809-814.
126. Mohan, R., Chintala, S. K., Jung, J. C., Villar, W. V., McCabe, F., Russo, L. A., Lee, Y., McCarthy, B. E., Wollenberg, K. R., Jester, J. V., Wang, M., Welgus, H. G., Shipley, J. M., Senior, R. M. and Fini, M. E. (2002) Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J. Biol. Chem. 277, 2065-2072.
127. Lelongt, B., Bengatta, S., Delauche, M., Lund, L. R., Werb, Z. and Ronco, P. M. (2001) Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity. J. Exp. Med. 193, 793-802.
128. Oikarinen, A., Kylmäniemi, M., Autio-Harmainen, H., Autio, P. and Salo, T. (1993) Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: variable expression in various blistering diseases, induction during reepithelialization, and decrease by topical glucocorticoids. J. Invest. Dermatol. 101, 205-210.
129. Galvez, B. G., Matias-Roman, S., Yanez-Mo, M., Sanchez-Madrid, F. and Arroyo, A. G. (2002) ECM regulates MT1-MMP localization with β1 or αlVβ3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells. J. Cell Biol. 159, 509-521.
130. Kato, T., Kure, T., Chang, J. H., Gabison, E. E., Itoh, T., Itohara, S. and Azar, D. T. (2001) Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett. 508, 187-190.
131. Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H. and Itohara, S. (1998) Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58, 1048-1051.
132. Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M. and Werb, Z. (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422.
133. Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z. and Hanahan, D. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2, 737-744.
134. Gearing, A. J., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L. Leber, M., Mangan, M., Miller, K., Nayee, P., Owen, K., Patel, S., Thomas, W., Wells, G., Wood, L. M. and Woolley, K. (1994) Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370, 555-557.
135. Dean, R. A., Butler, G. S., Hamma-Kourbali, Y., Delbe, J., Brigstock, D. R., Courty, J. and Overall, C. M. (2007) Identification of Candidate Angiogenic Inhibitors Processed by MMP-2 in Cell Based Proteomic Screens: Disruption of VEGF/HARP (Pleiotrophin) and VEGF/ CTGFAngiogenic Inhibitory Complexes by MMP-2 Proteolysis. Mol. Cell. Biol. 27, 8454-8465.
136. Heljäsvaara, R., Nyberg, P., Luostarinen, J., Parikka, M., Heikkilä, P., Rehn, M., Sorsa, T., Salo, T. and Pihlajaniemi, T. (2005) Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases. Exp. Cell Res. 307, 292-304.
137. O'Reilly, M. S., Wiederschain, D., Stetler-Stevenson, W. G., Folkman, J. and Moses, M. A. (1999) Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J. Biol. Chem. 274, 29568-29571.
138. Cornelius, L. A., Nehring, L. C., Harding, E., Bolanowski, M., Welgus, H. G., Kobayashi, D. K., Pierce, R. A. and Shapiro, S. D. (1998) Matrix metalloproteinases generate angiostatin: effects on neovascularization. J. Immunol. 161, 6845-6852.
139. Levi, E., Fridman, R., Miao, H. Q., Ma, Y. S., Yayon, A. and Vlodavsky, I. (1996) Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc. Natl. Acad. Sci. U. S. A. 93, 7069-7074.
140. Hiraoka, N., Allen, E., Apel, I. J., Gyetko, M. R. and Weiss, S. J. (1998) Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95, 365-377.
141. Chun, T. H., Sabeh, F., Ota, I., Murphy, H., McDonagh, K. T., Holmbeck, K., Birkedal-Hansen, H., Allen, E. D. and Weiss, S. J. (2004) MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J. Cell Biol. 167, 757-767.
142. Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A. and Goldberg, G. I. (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270, 5331-5338.
143. Okada, A., Tomasetto, C., Lutz, Y., Bellocq, J. P., Rio, M. C. and Basset, P. (1997) Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of progelatinase A. J. Cell Biol. 137, 67-77.
144. Mirastschijski, U., Impola, U., Karsdal, M. A., Saarialho-Kere, U. and Ågren, M. S. (2002) Matrix metalloproteinase inhibitor BB-3103 unlike the serine proteinase inhibitor aprotinin abrogates epidermal healing of human skin wounds ex vivo. J. Invest. Dermatol. 118, 55-64.
145. Sabeh, F., Ota, I., Holmbeck, K., Birkedal-Hansen, H., Soloway, P., Balbin, M., Lopez-Otin, C., Shapiro, S., Inada, M., Krane, S., Allen, E., Chung, D. and Weiss, S. J. (2004) Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J. Cell Biol. 167, 769-781.
146. Zhou, Z., Apte, S. S., Soininen, R., Cao, R., Baaklini, G. Y., Rauser, R. W., Wang, J., Cao, Y. and Tryggvason, K. (2000) Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl. Acad. Sci. U. S. A. 97, 4052-4057.
147. Mirastschijski, U., Zhou, Z., Rollman, O., Tryggvason, K. and Ågren, M. S. (2004) Wound healing in membrane-type-1 matrix metalloproteinase-deficient mice. J. Invest. Dermatol. 123, 600-602.
148. Impola, U., Toriseva, M., Suomela, S., Jeskanen, L., Hieta, N., Jahkola, T., Grenman, R., Kähäri, V.-M. and Saarialho-Kere, U. (2003) Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation. Int. J. Cancer 103, 709-716.
149. Sadowski, T., Dietrich, S., Koschinsky, F., Ludwig, A., Proksch, E., Titz, B. and Sedlacek, R. (2005) Matrix metalloproteinase 19 processes the laminin 5 γ2 chain and induces epithelial cell migration. Cell. Mol. Life Sci. 62, 870-880.
150. Sadowski, T., Dietrich, S., Koschinsky, F. and Sedlacek, R. (2003) Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3. Mol. Biol. Cell 14, 4569-4580.
151. Beck, I. M., Muller, M., Mentlein, R., Sadowski, T., Mueller, M. S., Paus, R. and Sedlacek, R. (2007) Matrix metalloproteinase-19 expression in keratinocytes is repressed by transcription factors Tst-1 and Skn-1a: implications for keratinocyte differentiation. J. Invest. Dermatol. 127, 1107-1114.
152. Titz, B., Dietrich, S., Sadowski, T., Beck, C., Petersen, A. and Sedlacek, R. (2004) Activity of MMP-19 inhibits capillary-like formation due to processing of nidogen-1. Cell. Mol. Life Sci. 61, 1826-1833.
153. Jost, M., Folgueras, A. R., Frerart, F., Pendas, A. M., Blacher, S., Houard, X., Berndt, S., Munaut, C., Cataldo, D., Alvarez, J., Melen-Lamalle, L., Foidart, J. M., Lopez-Otin, C. and Noel, A. (2006) Earlier onset of tumoral angiogenesis in matrix metalloproteinase-19-deficient mice. Cancer Res. 66, 5234-5241.
154. Vaalamo, M., Kariniemi, A. L., Shapiro, S. D. and Saarialho-Kere, U. (1999) Enhanced expression of human metalloelastase (MMP-12) in cutaneous granulomas and macrophage migration. J. Invest. Dermatol. 112, 499-505.
155. Hiller, O., Lichte, A., Oberpichler, A., Kocourek, A. and Tschesche, H. (2000) Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. J. Biol. Chem. 275, 33008-33013.
156. Pirilä, E., Korpi, J. T., Korkiamäki, T., Jahkola, T., Gutierrez-Fernandez, A., Lopez-Otin, C., Saarialho-Kere, U., Salo, T. and Sorsa, T. (2007) Collagenase-2 (MMP-8) and matrilysin-2 (MMP-26) expression in human wounds of different etiologies. Wound Repair Regen. 15, 47-57.
157. Marchenko, N. D., Marchenko, G. N., Weinreb, R. N., Lindsey, J. D., Kyshtoobayeva, A., Crawford, H. C. and Strongin, A. Y. (2004) β-catenin regulates the gene of MMP-26, a novel metalloproteinase expressed both in carcinomas and normal epithelial cells. Int. J. Biochem. Cell Biol. 36, 942-956.
158. Saarialho-Kere, U., Kerkelä, E., Jahkola, T., Suomela, S., Keski-Oja, J. and Lohi, J. (2002) Epilysin (MMP-28) expression is associated with cell proliferation during epithelial repair. J. Invest. Dermatol. 119, 14-21.
159. Illman, S. A., Lehti, K., Keski-Oja, J. and Lohi, J. (2006) Epilysin (MMP-28) induces TGF-β mediated epithelial to mesenchymal transition in lung carcinoma cells. J. Cell Sci. 119, 3856-3865.
160. Stricklin, G. P., Li, L., Jancic, V., Wenczak, B. A. and Nanney, L. B. (1993) Localization of mRNAs representing collagenase and TIMP in sections of healing human burn wounds. Am. J. Pathol. 143, 1657-1666.
161. Lambert, E., Dasse, E., Haye, B. and Petitfrere, E. (2004) TIMPs as multifacial proteins. Crit. Rev. Oncol. Hematol. 49, 187-198.
162. Scott, K. A., Wood, E. J. and Karran, E. H. (1998) A matrix metalloproteinase inhibitor which prevents fibroblast-mediated collagen lattice contraction. FEBS Lett. 441, 137-140.
163. Mäkelä, M., Larjava, H., Pirilä, E., Maisi, P., Salo, T., Sorsa, T. and Uitto, V. J. (1999) Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes. Exp. Cell Res. 251, 67-78.
164. Mirastschijski, U., Haaksma, C. J., Tomasek, J. J. and Ågren, M. S. (2004) Matrix metalloproteinase inhibitor GM 6001 attenuates keratinocyte migration, contraction and myofibroblast formation in skin wounds. Exp. Cell Res. 299, 465-475.
165. Solorzano, C. C., Ksontini, R., Pruitt, J. H., Auffenberg, T., Tannahill, C., Galardy, R. E., Schultz, G. P., MacKay, S. L., Copeland, E. M., 3rd and Moldawer, L. L. (1997) A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor-α (TNF-α) and abrogates endotoxin-induced lethality. Shock 7, 427-431.
166. Kruse, M. N., Becker, C., Lottaz, D., Kohler, D., Yiallouros, I., Krell, H. W., Sterchi, E. E. and Stocker, W. (2004) Human meprin α and β homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors. Biochem. J. 378, 383-389.
167. Franzke, C. W., Tasanen, K., Schacke, H., Zhou, Z., Tryggvason, K., Mauch, C., Zigrino, P., Sunnarborg, S., Lee, D. C., Fahrenholz, F. and Bruckner-Tuderman, L. (2002) Transmembrane collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMs. EMBO J. 21, 5026-5035.
168. Zigrino, P., Steiger, J., Fox, J. W., Loffek, S., Schild, A., Nischt, R. and Mauch, C. (2007) Role of ADAM-9 disintegrin-cysteine rich domains in human keratinocyte migration. J. Biol. Chem. 282, 30785-30793.
169. Schelfhout, V. R., Coene, E. D., Delaey, B., Waeytens, A. A., De Rycke, L., Deleu, M. and De Potter, C. R. (2002) The role of heregulin-α as a motility factor and amphiregulin as a growth factor in wound healing. J. Pathol. 198, 523-533.
170. Draper, B. K., Komurasaki, T., Davidson, M. K. and Nanney, L. B. (2003) Topical epiregulin enhances repair of murine excisional wounds. Wound Repair Regen. 11, 188-197.
171. Strachan, L., Murison, J. G., Prestidge, R. L., Sleeman, M. A., Watson, J. D. and Kumble, K. D. (2001) Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily. J. Biol. Chem. 276, 18265-18271.
172. Tokumaru, S., Higashiyama, S., Endo, T., Nakagawa, T., Miyagawa, J. I., Yamamori, K., Hanakawa, Y., Ohmoto, H., Yoshino, K., Shirakata, Y., Matsuzawa, Y., Hashimoto, K. and Taniguchi, N. (2000) Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J. Cell Biol. 151, 209-220.
173. Izumi, Y., Hirata, M., Hasuwa, H., Iwamoto, R., Umata, T., Miyado, K., Tamai, Y., Kurisaki, T., Sehara-Fujisawa, A., Ohno, S. and Mekada, E. (1998) A metalloprotease-disintegrin, MDC9/meltrin-γ/ADAM9 and PKCδ are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 17, 7260-7272.
174. Maretzky, T., Reiss, K., Ludwig, A., Buchholz, J., Scholz, F., Proksch, E., de Strooper, B., Hartmann, D. and Saftig, P. (2005) ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and β-catenin translocation. Proc. Natl. Acad. Sci. U. S. A. 102, 9182-9187.
175. Nagano, O., Murakami, D., Hartmann, D., De Strooper, B., Saftig, P., Iwatsubo, T., Nakajima, M., Shinohara, M. and Saya, H. (2004) Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J. Cell Biol. 165, 893-902.
176. Hundhausen, C., Schulte, A., Schulz, B., Andrzejewski, M. G., Schwarz, N., von Hundelshausen, P., Winter, U., Paliga, K., Reiss, K., Saftig, P., Weber, C. and Ludwig, A. (2007) Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes. J. Immunol. 178, 8064-8072.
177. Garton, K. J., Gough, P. J., Blobel, C. P., Murphy, G., Greaves, D. R., Dempsey, P. J. and Raines, E. W. (2001) Tumor necrosis factor-α-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J. Biol. Chem. 276, 37993-38001.
178. Herren, B., Raines, E. W. and Ross, R. (1997) Expression of a disintegrin-like protein in cultured human vascular cells and in vivo. FASEB J. 11, 173-180.
179. Horiuchi, K., Weskamp, G., Lum, L., Hammes, H. P., Cai, H., Brodie, T. A., Ludwig, T., Chiusaroli, R., Baron, R., Preissner, K. T., Manova, K. and Blobel, C. P. (2003) Potential role for ADAM15 in pathological neovascularization in mice. Mol. Cell. Biol. 23, 5614-5624.
180. Trochon-Joseph, V., Martel-Renoir, D., Mir, L. M., Thomaidis, A., Opolon, P., Connault, E., Li, H., Grenet, C., Fauvel-Lafeve, F., Soria, J., Legrand, C., Soria, C., Perricaudet, M. and Lu, H. (2004) Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin. Cancer Res. 64, 2062-2069.
181. Langer, H., May, A. E., Bultmann, A. and Gawaz, M. (2005) ADAM15 is an adhesion receptor for platelet GPIIb-IIIa and induces platelet activation. Thromb. Haemost. 94, 555-561.
182. Krampert, M., Kuenzle, S., Thai, S. N., Lee, N., Iruela-Arispe, M. L. and Werner, S. (2005) ADAMTS1 proteinase is upregulated in wounded skin and regulates migration of fibroblasts and endothelial cells. J. Biol. Chem. 280, 23844-23852.
183. Iruela-Arispe, M. L., Carpizo, D. and Luque, A. (2003) ADAMTS1: a matrix metalloprotease with angioinhibitory properties. Ann. NYAcad. Sci. 995, 183-190.
184. Lee, N. V., Sato, M., Annis, D. S., Loo, J. A., Wu, L., Mosher, D. F. and Iruela-Arispe, M. L. (2006) ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2. EMBO J. 25, 5270-5283.
185. Zheng, X., Majerus, E. M. and Sadler, J. E. (2002) ADAMTS13 and TTP. Curr. Opin. Hematol. 9, 389-394.
186. Menke, N. B., Ward, K. R., Witten, T. M., Bonchev, D. G. and Diegelmann, R. F. (2007) Impaired wound healing. Clin. Dermatol. 25, 19-25.
187. Wysocki, A. B., Staiano-Coico, L. and Grinnell, F. (1993) Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J. Invest. Dermatol. 101, 64-68.
188. Yager, D. R., Zhang, L. Y., Liang, H. X., Diegelmann, R. F. and Cohen, I. K. (1996) Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J. Invest. Dermatol. 107, 743-748.
189. Rayment, E. A., Upton, Z. and Shooter, G. K. (2008) Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer. Br. J. Dermatol. 29, 951-961.
190. Bullen, E. C., Longaker, M. T., Updike, D. L., Benton, R., Ladin, D., Hou, Z. and Howard, E. W. (1995) Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J. Invest. Dermatol. 104, 236-240.
191. Lobmann, R., Ambrosch, A., Schultz, G., Waldmann, K., Schiweck, S. and Lehnert, H. (2002) Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 45, 1011-1016.
192. Cook, H., Davies, K. J., Harding, K. G. and Thomas, D. W. (2000) Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity. J. Invest. Dermatol. 115, 225-233.
193. Kanangat, S., Postlethwaite, A., Hasty, K., Kang, A., Smeltzer, M., Appling, W. and Schaberg, D. (2006) Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections. Arthritis Res. Ther. 8, R176.
194. Wall, S. J., Bevan, D., Thomas, D. W., Harding, K. G., Edwards, D. R. and Murphy, G. (2002) Differential expression of matrix metalloproteinases during impaired wound healing of the diabetes mouse. J. Invest. Dermatol. 119, 91-98.
195. Weckroth, M., Vaheri, A., Virolainen, S., Saarialho-Kere, U., Jahkola, T. and Siren, V. (2004) Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers. Br. J. Dermatol. 151, 1189-1196.
196. Robles, D. T. and Berg, D. (2007) Abnormal wound healing: keloids. Clin. Dermatol. 25, 26-32.
197. Lee, T. Y., Chin, G. S., Kim, W. J., Chau, D., Gittes, G. K. and Longaker, M. T. (1999) Expression of transforming growth factor β 1, 2, and 3 proteins in keloids. Ann. Plast. Surg. 43, 179-184.
198. Ghahary, A., Shen, Y. J., Scott, P. G., Gong, Y. and Tredget, E. E. (1993) Enhanced expression of mRNA for transforming growth factor-β, type I and type III procollagen in human post-burn hypertrophic scar tissues. J. Lab. Clin. Med. 122, 465-473.
199. Fujiwara, M., Muragaki, Y. and Ooshima, A. (2005) Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br. J. Dermatol. 153, 295-300.
200. Diegelmann, R. F., Cohen, I. K. and McCoy, B. J. (1979) Growth kinetics and collagen synthesis of normal skin, normal scar and keloid fibroblasts in vitro. J. Cell. Physiol. 98, 341-346.
201. Ehrlich, H. P., Desmouliere, A., Diegelmann, R. F., Cohen, I. K., Compton, C. C., Garner, W. L., Kapanci, Y. and Gabbiani, G. (1994) Morphological and immunochemical differences between keloid and hypertrophic scar. Am. J. Pathol. 145, 105-113.
202. Ghahary, A., Shen, Y. J., Nedelec, B., Wang, R., Scott, P. G. and Tredget, E. E. (1996) Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1. J. Invest. Dermatol. 106, 476-481.
203. Neely, A. N., Clendening, C. E., Gardner, J., Greenhalgh, D. G. and Warden, G. D. (1999) Gelatinase activity in keloids and hypertrophic scars. Wound Repair Regen. 7, 166-171.
204. Kuo, Y. R., Wu, W. S., Jeng, S. F., Wang, F. S., Huang, H. C., Lin, C. Z. and Yang, K. D. (2005) Suppressed TGF-β1 expression is correlated with up-regulation of matrix metalloproteinase-13 in keloid regression after flashlamp pulsed-dye laser treatment. Lasers Surg. Med. 36, 38-42.
205. Heino, J. (2000) The collagen receptor integrins have distinct ligand recognition and signaling functions. Matrix Biol. 19, 319-323.
206. Tuan, T. L., Zhu, J. Y., Sun, B., Nichter, L. S., Nimni, M. E. and Laug, W. E. (1996) Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J. Invest. Dermatol. 106, 1007-1011.
207. Bullard, K. M., Longaker, M. T. and Lorenz, H. P. (2003) Fetal wound healing: current biology. World J. Surg. 27, 54-61.
208. Häkkinen, L., Uitto, V. J. and Larjava, H. (2000) Cell biology of gingival wound healing. Periodontol. 24, 127-152.
209. Irwin, C. R., Myrillas, T., Smyth, M., Doogan, J., Rice, C. and Schor, S. L. (1998) Regulation of fibroblast-induced collagen gel contraction by interleukin-1β. J. Oral Pathol. Med. 27, 255-259.
210. Shah, M., Foreman, D. M. and Ferguson, M. W. (1995) Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J. Cell Sci. 108 ( Pt 3), 985-1002.
211. Chen, W., Fu, X., Ge, S., Sun, T. and Sheng, Z. (2007) Differential expression of matrix metalloproteinases and tissue-derived inhibitors of metalloproteinase in fetal and adult skins. Int. J. Biochem. Cell Biol. 39, 997-1005.
212. Peled, Z. M., Phelps, E. D., Updike, D. L., Chang, J., Krummel, T. M., Howard, E. W. and Longaker, M. T. (2002) Matrix metalloproteinases and the ontogeny of scarless repair: the other side of the wound healing balance. Plast. Reconstr. Surg. 110, 801-811.
213. Dang, C. M., Beanes, S. R., Lee, H., Zhang, X., Soo, C. and Ting, K. (2003) Scarless fetal wounds are associated with an increased matrix metalloproteinase-to-tissue-derived inhibitor of metalloproteinase ratio. Plast. Reconstr. Surg. 111, 2273-2285.
214. Deng, S. J., Bickett, D. M., Mitchell, J. L., Lambert, M. H., Blackburn, R. K., Carter, H. L., 3rd, Neugebauer, J., Pahel, G., Weiner, M. P. and Moss, M. L. (2000) Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library. J. Biol. Chem. 275, 31422-31427.
215. Ravanti, L., Häkkinen, L., Larjava, H., Saarialho-Kere, U., Foschi, M., Han, J. and Kähäri, V.-M. (1999) Transforming growth factor-b induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J. Biol. Chem. 274, 37292-37300.
216. Stephens, P., Davies, K. J., Occleston, N., Pleass, R. D., Kon, C., Daniels, J., Khaw, P. T. and Thomas, D. W. (2001) Skin and oral fibroblasts exhibit phenotypic differences in extracellular matrix reorganization and matrix metalloproteinase activity. Br. J. Dermatol. 144, 229-237.
217. Huang, E. Y., Wu, H., Island, E. R., Chong, S. S., Warburton, D., Anderson, K. D. and Tuan, T. L. (2002) Differential expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in early and late gestational mouse skin and skin wounds. Wound Repair Regen. 10, 387-396.
218. Veves, A., Sheehan, P. and Pham, H. T. (2002) A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch. Surg. 137, 822-827.
219. Vin, F., Teot, L. and Meaume, S. (2002) The healing properties of Promogran in venous leg ulcers. J. Wound Care 11, 335-341.
220. Kakagia, D. D., Kazakos, K. J., Xarchas, K. C., Karanikas, M., Georgiadis, G. S., Tripsiannis, G. and Manolas, C. (2007) Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers. A prospective randomized trial. J. Diabetes Complications 21, 387-391.
221. Chin, G. A., Thigpin, T. G., Perrin, K. J., Moldawer, L. L. and Schultz, G. S. (2003) Treatment of chronic ulcers in diabetic patients with a topical metalloproteinase inhibitor, doxycycline. Wounds 15, 315-323.
222. Blobe, G. C., Schiemann, W. P. and Lodish, H. F. (2000) Role of transforming growth factor b in human disease. N. Engl. J. Med. 342, 1350-1358.
223. Manuel, J. A. and Gawronska-Kozak, B. (2006) Matrix metalloproteinase 9 (MMP-9) is upregulated during scarless wound healing in athymic nude mice. Matrix Biol. 25, 505-514.
224. Brown, G. L., Nanney, L. B., Griffen, J., Cramer, A. B., Yancey, J. M., Curtsinger, L. J., 3rd, Holtzin, L., Schultz, G. S., Jurkiewicz, M. J. and Lynch, J. B. (1989) Enhancement of wound healing by topical treatment with epidermal growth factor. N. Engl. J. Med. 321, 76-79.
225. Laato, M., Kähäri, V.-M., Niinikoski, J. and Vuorio, E. (1987) Epidermal growth factor increases collagen production in granulation tissue by stimulation of fibroblast proliferation and not by activation of procollagen genes. Biochem. J. 247, 385-388.
226. Mimura, Y., Ihn, H., Jinnin, M., Asano, Y., Yamane, K. and Tamaki, K. (2006) Epidermal growth factor affects the synthesis and degradation of type I collagen in cultured human dermal fibroblasts. Matrix Biol. 25, 202-212.
227. Shirakata, Y., Kimura, R., Nanba, D., Iwamoto, R., Tokumaru, S., Morimoto, C., Yokota, K., Nakamura, M., Sayama, K., Mekada, E., Higashiyama, S. and Hashimoto, K. (2005) Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J. Cell Sci. 118, 2363-2370.
228. Bevan, D., Gherardi, E., Fan, T. P., Edwards, D. and Warn, R. (2004) Diverse and potent activities of HGF/SFin skin wound repair. J. Pathol. 203, 831-838.
229. Werner, S. (1998) Keratinocyte growth factor: a unique player in epithelial repair processes. Cytokine Growth Factor Rev. 9, 153-165.
230. Andreadis, S. T., Hamoen, K. E., Yarmush, M. L. and Morgan, J. R. (2001) Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system. FASEB J. 15, 898-906.
231. Breen, E. C. (2007) VEGF in biological control. J. Cell. Biochem. 102, 1358-1367.
232. Edmondson, S. R., Thumiger, S. P., Werther, G. A. and Wraight, C. J. (2003) Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems. Endocr. Rev. 24, 737-764.